StocksDeepDive
Snapshot · FTSE 250 · generated 2026-10-13 03:44 UTC

THRL.L — Target Healthcare REIT Ord

EXPENSIVE (MOS -51.9%) · Quality 50/100

Price
1.12
Intrinsic value
0.74
Margin of safety
-51.9%
Implied growth (reverse DCF)
+13.7%
model assumes +5.9%
Value Score
6.9
Quality
50
Psychology
2.8
Discovery
2
price/volume attention only
Moat score
n/a
erosion: none

Value Score: bottom 10% of FTSE 250 · Quality: bottom 27%

Dividend: 0.0603/share (TTM) · yield 5.4% · payout 51%

Open the interactive Deep Dive for THRL.L →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/THRL.L - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is THRL.L undervalued?

As of 2026-10-13, THRL.L trades at 1.12 against a computed intrinsic value of 0.74 (-51.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Target Healthcare REIT Ord's Value Score?

Target Healthcare REIT Ord's Value Score is 6.9 as of 2026-10-13 - it combines value, quality, crowd psychology and market attention into one number.

Does THRL.L pay a dividend?

Yes - THRL.L's trailing twelve-month dividend is 0.0603/share, a yield of 5.4% at the current price (as of 2026-10-13).